|27.43|| +1.58 / +6.11%|
SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics. The Medical Device segment engages in contract research and development, as well as manufacturing of balloons catheters used for a variety of interventional cardiology applications. The In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.
|Gary R. Maharaj||President, Chief Executive Officer & Director|
|Thomas A. Greaney||Vice President-Operations|
|Andrew D. C. LaFrence||CFO, VP & Head-Investor Relations|
|Gregg S. Sutton||Vice President-Research & Development|
|Charles W. Olson||Senior Vice President & GM-Medical Device|